TrialPain medicine (Malden, Mass.)2020

Long-term Safety and Tolerability of NKTR-181 in Patients with Moderate to Severe Chronic Low Back Pain or Chronic Noncancer Pain: A Phase 3 Multicenter, Open-Label, 52-Week Study (SUMMIT-08 LTS).

Jeffrey Gudin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.